0001587661-22-000001.txt : 20220103 0001587661-22-000001.hdr.sgml : 20220103 20220103103815 ACCESSION NUMBER: 0001587661-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220103 DATE AS OF CHANGE: 20220103 EFFECTIVENESS DATE: 20220103 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Artax Biopharma, Inc. CENTRAL INDEX KEY: 0001587661 IRS NUMBER: 462543689 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-427556 FILM NUMBER: 22500894 BUSINESS ADDRESS: STREET 1: 1 BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-368-0676 MAIL ADDRESS: STREET 1: 1 BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 D 1 primary_doc.xml X0708 D LIVE 0001587661 Artax Biopharma, Inc. 1 BROADWAY 14TH FLOOR CAMBRIDGE MA MASSACHUSETTS 02142 617-368-0676 DELAWARE None None Corporation true Joseph M. Lobacki c/o Artax Biopharma, Inc. 1 Broadway, 14th Floor Cambridge MA MASSACHUSETTS 02142 Executive Officer Director Damia Tormo, Ph.D. c/o Artax Biopharma, Inc. 1 Broadway, 14th Floor Cambridge MA MASSACHUSETTS 02142 Director Robert Armstrong, Ph.D. c/o Artax Biopharma, Inc. 1 Broadway, 14th Floor Cambridge MA MASSACHUSETTS 02142 Director Gino Santini c/o Artax Biopharma, Inc. 1 Broadway, 14th Floor Cambridge MA MASSACHUSETTS 02142 Director Alan E. Walts c/o Artax Biopharma, Inc. 1 Broadway, 14th Floor Cambridge MA MASSACHUSETTS 02142 Director Biotechnology Decline to Disclose 06b false 2021-12-17 false true false 0 23182328 12686325 10496003 false 25 0 0 0 false Artax Biopharma, Inc. /s/ Joseph M. Lobacki Joseph M. Lobacki President and CEO 2021-12-30